Skip to content

Evaluation of the effects of prophylactic misoprostol with oxytocin for postpartum hemorrhage in women with preeclampsia

Evaluation of the Efficacy of Rectal or Sub-linguinal Misoprostol concomitant with Oxytocin for Prevention of Postpartum Hemorrhage in women with preeclampsia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201022049108N1
Enrollment
128
Registered
2020-11-05
Start date
2020-11-21
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe pre-eclampsia. Severe pre-eclampsia, third trimester

Interventions

Intervention 1: Intervention group: Oral misoprostol manufactured in Aboorehyan pharmacy CO, Iran, give to patients sublingually after C-section it is in combination with conventional treatment that i

Sponsors

Karaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: ALL pregnant mothers with severe pre-eclampsia who referred to the Shahi Kamali educational center in the study period Hospitalization for C-section Gestational age over 35 weeks Having a healthy and alive fetus Cephalic fetus A maximum of 2 previous cesarean sections Complete removal of the placenta after cesarean section The age of 18-45 years

Exclusion criteria

Exclusion criteria: Mothers with coagulation disorders History of maternal blood disorders Chronic hypertension Placental adhesion such as placenta previa and ecrta Placental abruption (overt and covert) Complications or emergency during surgery Eclampsia Mild pre-eclampsia Abnormal placenta History of uterine rupture High bleeding risk Indication for hysterectomy or TL

Design outcomes

Primary

MeasureTime frame
Bleeding volume with gauze counting. Timepoint: Immediately, 1 hour, and 4 hours after C-section. Method of measurement: gauze counting.;Hemoglobin and hematocrit changes. Timepoint: 24 hours after C-section. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMansooreh Sadeghi Afkham

Karaj University of Medical Sciences

m.sadeh.2003@gmail.com+98 26 3222 2021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026